Close Menu
    Thursday, December 5
    Subscribe Contact us
    BROWSE BY :
    OrbiMed

    OrbiMed

    Estd. 1989
    Investor

    OrbiMed is a corporate venture capital and private equity firm based in New York City. Founded in 1989, the firm seeks to invest in life sciences, pharmaceuticals, biopharma, digital health, diagnostics, healthcare services, healthcare technology, and more.

    New York, United States

    Investors

    No data was found

    Investees

    Alentis Therapeutics

    Alentis Therapeutics

    ESTD: 2019
    Health Tech Product

    Job

    No data was found

    Funding News Related To OrbiMed

    Alentis Therapeutics Secures 1M to Advance Targeted Therapies for Solid Tumors
    181.4 M
    Series D

    Alentis Therapeutics Secures $181M to Advance Targeted Therapies for Solid Tumors

    Alentis Therapeutics, a leading biopharmaceutical company developing targeted treatments for cancer and fibrotic diseases, has secured $181.4 million in Series D funding round to develop

    OrbiMed

    Next Digital Health is your healthcare technologies and wellness technologies site. We provide you with the latest technology news and videos straight from the healthcare, pharmacy and wellness industries.

    Contact us: info@nextdigitalhealth.com

    Facebook Linkedin Twitter Youtube

    Powered by Wi4.org

    Privacy Policy

    Join our Mailing list!

    Get all latest news, exclusive deals and updates.